4.6 (792) · $ 9.00 · In stock
SEC Filing ProQR Therapeutics
Leerink: Translate Bio's Cystic Fibrosis Candidate Could Generate $1.8B
F-1/A
The top 10 biopharma M&A deals in 2021
With $3.2B, Sanofi takes in mRNA partner Translate Bio in buyout deal
11 biotechs primed to make billion-dollar buys and usurp Big Pharma
tbio-10k_20181231.htm
SEC Filing ProQR Therapeutics
grph-10k_20211231.htm
grph-10k_20211231.htm
EX-99.1
IJMS, Free Full-Text
SEC Filing AN2 Therapeutics, Inc
tbio-10k_20181231.htm